研究疾病:
|
双心疾病
|
研究疾病代码:
|
|
Target disease:
|
double heart disease
|
Target disease code:
|
研究类型:
Study type:
|
干预性研究
Interventional study
|
研究设计:
Study design:
|
随机平行对照
randomized controlled trial(parallel group design)
|
研究所处阶段:
Study phase:
|
上市后药物
Post-marketing clinical trial
|
研究目的:
|
本研究是一项安慰剂对照、随机、前瞻性、双盲的研究,旨在观察振源胶囊治疗冠心病合并心理障碍病人的临床疗效。
|
Objectives of Study:
|
This study is a placebo-controlled, randomized, prospective, double-blind study to observe the clinical efficacy of Zhenyuan capsule in the treatment of patients with coronary heart disease and mental disorders.
|
药物成份或治疗方案详述:
|
依据随机数字表法将受试者分为振源胶囊组和对照组,对照组为常规标准治疗,振源胶囊组为常规标准治疗+振源胶囊2粒,每日3次,疗程6周
|
Description for medicine or protocol of treatment in detail:
|
According to the method of random number table, the subjects were divided into Zhenyuan Capsule Group and Control Group. The Control Group was treated with conventional standard therapy, and Zhenyuan Capsule Group was treated with conventional standard therapy + Zhenyuan Capsule 2 times daily for 6 weeks.
|
纳入标准:
|
冠心病:包括稳定型心绞痛(SAP)、不稳定型心绞痛(UA)、急性非ST段抬高型心肌梗死(NSTEMI)、急性ST段抬高型心肌梗死(STEMI)。
SAP诊断标准:根据典型的发作特点和体征,休息或含用硝酸甘油后缓解,结合年龄和存在的其他冠心病危险因素,除外其他疾病所致的心绞痛,即可建立诊断。
发作时心电图检查可见以R波为主的导联中,ST段压低,T波平坦或倒置,发作过后数分钟内逐渐恢复。发作不典型者诊断要依靠观察硝酸甘油的疗效和发作时心电图的变化。
UA/NSTEMI诊断标准:根据病史典型的心绞痛症状、典型的缺血性心电图改变(新发或一过性ST段压低≥0.lmV,或T波倒置≥0.2mV)。以及心肌损伤标志物(cTnT、cTnI或CK-MN)测定。
STEMI:指急性心肌损伤血清心脏肌钙蛋白(cardiac troponin,cTn)增高和/或回落,且至少1次高于正常值上限(参考值上限值的99百分位值),同时有急性心肌缺血的临床证据,包括:(1)急性心肌缺血症状;(2)新的缺血性心电图改变;(3)新发病理性Q波;(4)新的存活心肌丢失或室壁节段运动异常的影像学证据;(5)冠状动脉造影或腔内影像学检查证实冠状动脉血栓。
心理疾病:
焦虑诊断标准:HAMA评分≥14分;
抑郁诊断标准:HAMD评分≥8分;SDS评分≥53分;
年龄在18~75岁,性别不限;
患者及家属自愿参与实验,并且能够配合签署知情同意书;
|
Inclusion criteria
|
Coronary heart disease: include stable Angina (SAP), unstable Angina (UA) , Acute non-ST segment elevation myocardial infarction (NSTEMI) , Acute St Segment Elevation Myocardial Infarction (Stemi).
SAP DIAGNOSTIC CRITERIA: A diagnosis can be established on the basis of typical seizure characteristics and signs, remissions after rest or Nitroglycerin, in combination with age and the presence of other risk factors for coronary heart disease, except Angina caused by other diseases.
Mental Illness:
DIAGNOSTIC CRITERIA FOR ANXIETY: Hama score >= 14;
Diagnostic criteria for depression: Hamd Score >= 8; SDS score >= 53;
Age: 18 to 75 years old, sex is not limited;
Patients and their families volunteered for the trial and were able to sign informed consent forms.
During the attack, the ECG showed that ST segment was depressed, t wave was flat or inverted, and recovered gradually within a few minutes after the attack.
UA/NSTEMI DIAGNOSTIC CRITERIA: Typical Angina symptoms, typical ISCHEMIC ECG changes (new or transient ST segment depression >= 0.1 MV, or t wave inversion. The diagnosis of atypical episodes depends on observing the effects of Nitroglycerin and changes in the electrocardiogram during the episode.>= 0.2 MV). And Myocardial Injury Markers (CTNT, cTnI or CK-MN) were measured.
STEMI: refers to an increase and/or decrease in Serum Cardiac Troponin (cTn) in acute myocardial injury at least once above the upper normal limit (99 percentile of the upper reference value) and clinical evidence of acute myocardial ISCHEMIA, including: (1) Acute Myocardial ischemia symptoms; (2) New ISCHEMIC ECG changes; (3) new pathological q waves; (4) new imaging evidence of viable myocardial loss or regional wall motion abnormalities; (5) coronary artery thrombosis was confirmed by coronary angiography or intracavitary imaging.
|
排除标准:
|
近期服用相关精神类药物;
风湿性心脏病、先天性心脏病、心肌病、肺心病、高血压性心脏病、老年性瓣膜病、心律失常等心脏病患者;
NYHA心功能IV级;
计划妊娠或已经妊娠妇女及哺乳期妇女;
理解、认知功能障碍等不能配合问卷调查;
对药物过敏者;
严重肝肾功能障碍;
研究者认为不适合参加者.
|
Exclusion criteria:
|
1. Use of psychoactive drugs recently;
2. Patients with rheumatic heart disease, congenital heart defect, cardiomyopathy, pulmonary heart disease, hypertensive heart disease, senile valvular disease, Arrhythmia and other heart diseases;
3. NYHA Class IV CARDIAC function;
4. Women who plan to have or have already had a pregnancy and women who are breastfeeding;
5. Understanding, cognitive dysfunction and so on can not cooperate with the questionnaire survey;
6. Drug allergy;
7. Severe Liver and kidney dysfunction;
8. The researchers don't think it was appropriate for the participants.
|
研究实施时间:
Study execute time:
|
从From
2021-01-01
至To
2023-12-31
|
征募观察对象时间:
Recruiting time:
|
从From
2021-01-01
至To
2022-12-31
|